# ETFs That Hold Sichuan Kelun-Biotech (6990)

> 32 thematic and core ETFs hold Sichuan Kelun-Biotech Biopharmaceutical Co Ltd (6990). FPXI holds the most, at 3.60% of the fund on Nov 3, 2026.

Data as of Nov 5, 2026. Rebuilt every trading night.

## ETFs that hold Sichuan Kelun-Biotech Biopharmaceutical Co Ltd

32 thematic and core ETFs hold Sichuan Kelun-Biotech Biopharmaceutical Co Ltd , by holdings dated Jun 30, 2026 to Nov 3, 2026 . FPXI holds the most, at 3.60% of the fund on Nov 3, 2026 . The next largest are IPOS (2.02%) and MCHS (1.50%).

### Thematic and core funds that hold it

| Fund | Name | Share of the fund | Holdings filed | Asset |
| --- | --- | --- | --- | --- |
| FPXI | First Trust International Equity Opportunities ETF | 3.60% | Nov 3, 2026 | Equity |
| IPOS | Renaissance International IPO ETF | 2.02% | Jun 30, 2026 | Equity |
| MCHS | Matthews China Innovators Active ETF | 1.50% | Jun 30, 2026 | Equity |
| NBCE | Neuberger China Equity ETF | 0.98% | Aug 31, 2026 | Equity |
| MINV | Matthews Asia Innovators Active ETF | 0.83% | Jun 30, 2026 | Equity |
| CXSE | WisdomTree China ex-State-Owned Enterprises Fund | 0.15% | Jun 30, 2026 | Equity |
| CNQQ | Rayliant-ChinaAMC Transformative China Tech ETF | 0.14% | Jun 30, 2026 | Equity |
| FLCH | Franklin FTSE China ETF | 0.14% | Jun 30, 2026 | Equity |
| GXC | State Street SPDR S&P China ETF | 0.09% | Nov 3, 2026 | Equity |
| EMCR | Xtrackers Emerging Markets Carbon Reduction and Climate Improvers ETF | 0.04% | Aug 31, 2026 | Equity |
| SCHE | Schwab Emerging Markets Equity ETF | 0.04% | Aug 31, 2026 | Equity |
| VWO | Vanguard FTSE Emerging Markets ETF | 0.04% | Sep 30, 2026 | Equity |
| GSEE | Goldman Sachs MarketBeta Emerging Markets Equity ETF | 0.03% | Aug 31, 2026 | Equity |
| DBEM | Xtrackers MSCI Emerging Markets Hedged Equity ETF | 0.03% | Aug 31, 2026 | Equity |
| EEMX | State Street SPDR MSCI Emerging Markets Fossil Fuel Reserves Free ETF | 0.03% | Nov 3, 2026 | Equity |
| FLAX | Franklin FTSE Asia ex Japan ETF | 0.02% | Jun 30, 2026 | Equity |
| XSOE | WisdomTree Emerging Markets ex-State-Owned Enterprises Fund | 0.02% | Jun 30, 2026 | Equity |
| BKEM | BNY Mellon Emerging Markets Equity ETF | 0.02% | Jul 31, 2026 | Equity |
| JSTC | Adasina Social Justice All Cap Global ETF | 0.02% | Aug 31, 2026 | Equity |
| JHEM | John Hancock Multifactor Emerging Markets ETF | 0.01% | Jun 30, 2026 | Equity |
| VSGX | Vanguard ESG International Stock ETF | 0.01% | Sep 30, 2026 | Equity |
| DFAE | Dimensional Emerging Core Equity Market ETF | 0.01% | Jul 31, 2026 | Equity |
| VEU | Vanguard FTSE All World Ex US ETF | 0.01% | Sep 30, 2026 | Equity |
| VXUS | Vanguard Total International Stock ETF | 0.01% | Sep 30, 2026 | Equity |
| DBAW | Xtrackers MSCI All World ex US Hedged Equity ETF | 0.01% | Aug 31, 2026 | Equity |
| GXUS | Goldman Sachs MarketBeta Total International Equity ETF | 0.01% | Aug 31, 2026 | Equity |
| TLTE | Northern Trust Morningstar Emerging Markets Factor Tilt ETF | 0.01% | Jul 31, 2026 | Equity |
| SPEM | State Street SPDR Portfolio Emerging Markets ETF | 0.01% | Nov 3, 2026 | Equity |
| DFEM | Dimensional Emerging Markets Core Equity 2 ETF | Sichuan Kelun-Biotech Biopharmaceutical Co Ltd (ticker 6990 HKG, listed in CN) is matched in every holdings book ETFIQ publishes, by its ticker and name. A share of the fund is the weight its issuer published, as of the Holdings filed date. Shares, preferred shares and debt are told by each fund’s N-PORT asset type. A fund holding only the company’s debt or preferred shares is listed under them, not counted as holding its shares. Options, swaps, futures and cash do not count as holding a company: a call option on a share is not the share. Funds whose book is gross exposure, not a portfolio, are left out.

Each row shows the date the fund last filed.

Look up another company .

### Questions people ask

Which ETFs hold Sichuan Kelun-Biotech Biopharmaceutical Co Ltd? 32 thematic and core ETFs hold Sichuan Kelun-Biotech Biopharmaceutical Co Ltd, by holdings dated Jun 30, 2026 to Nov 3, 2026. The largest positions are FPXI at 3.60% of the fund on Nov 3, 2026, IPOS at 2.02% of the fund on Jun 30, 2026 and MCHS at 1.50% of the fund on Jun 30, 2026.

---

Source: ETFIQ, independent ETF data. Recomputed nightly from public filings and prices.
Cite: ETFIQ, ETFs holding SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO LTD, data as of Nov 5, 2026. https://etfiq.com/holdings/6990/
Licence: https://etfiq.com/license/ Data ETFIQ computes is free to use with attribution: ETFIQ (etfiq.com). Issuer data stays under its owner's terms.
HTML: https://etfiq.com/holdings/6990/